- Home
- SEE vs TMDX Comparison
SEE vs TMDX Comparison
Compare SEE & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEE
- TMDX
- Stock Information
- Founded
- SEE 1960
- TMDX 1998
- Country
- SEE United States
- TMDX United States
- Employees
- SEE N/A
- TMDX N/A
- Industry
- SEE Major Chemicals
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SEE Industrials
- TMDX Health Care
- Exchange
- SEE Nasdaq
- TMDX Nasdaq
- Market Cap
- SEE 4.6B
- TMDX 3.9B
- IPO Year
- SEE N/A
- TMDX 2019
- Fundamental
- Price
- SEE $33.66
- TMDX $114.29
- Analyst Decision
- SEE Strong Buy
- TMDX Buy
- Analyst Count
- SEE 10
- TMDX 10
- Target Price
- SEE $38.80
- TMDX $122.11
- AVG Volume (30 Days)
- SEE 1.4M
- TMDX 959.4K
- Earning Date
- SEE 11-06-2025
- TMDX 10-27-2025
- Dividend Yield
- SEE 2.38%
- TMDX N/A
- EPS Growth
- SEE N/A
- TMDX 2163.11
- EPS
- SEE 1.98
- TMDX 2.02
- Revenue
- SEE $5,325,400,000.00
- TMDX $531,292,000.00
- Revenue This Year
- SEE N/A
- TMDX $38.86
- Revenue Next Year
- SEE $1.94
- TMDX $20.79
- P/E Ratio
- SEE $17.04
- TMDX $56.66
- Revenue Growth
- SEE N/A
- TMDX 48.09
- 52 Week Low
- SEE $22.78
- TMDX $55.00
- 52 Week High
- SEE $38.85
- TMDX $169.29
- Technical
- Relative Strength Index (RSI)
- SEE 63.78
- TMDX 49.62
- Support Level
- SEE $32.66
- TMDX $105.00
- Resistance Level
- SEE $34.21
- TMDX $119.36
- Average True Range (ATR)
- SEE 0.71
- TMDX 5.18
- MACD
- SEE 0.13
- TMDX 0.41
- Stochastic Oscillator
- SEE 77.73
- TMDX 72.39
About SEE Sealed Air Corporation
Sealed Air is organized via two reporting segments. Food includes food packaging products like Cryovac, Darfresh, and OptiDure aimed primarily at meats. Protective includes Sealed Air's Bubble Wrap, Instapak, Jiffy mailers, and shrink film packaging systems that cater to industrial and e-commerce applications.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.